Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Cardiac Implants Companies

Several companies are at the forefront of developing and manufacturing cardiac implants, including devices such as pacemakers, implantable defibrillators, and various other cardiovascular devices. These companies play a critical role in providing innovative solutions for the management and treatment of various cardiac conditions.

*Disclaimer: List of key companies in no particular orderLatest cardiac implants Companies Update

Aug 2023: With a share of 57% in the fiercely competitive US tissue suture aortic valve replacement industry as of 2022, Edwards Lifesciences was the market leader. Aortic valves manufactured by Edwards Lifesciences include the Perimount, Magna, and Inspiris Resilia models. Abbott Laboratories is a well-known competitor in the tissue sAVR industry, but it only holds a 5% market share thanks to its two products, the Trifecta GT aortic valve and Biocor Stent Tissue. The Trifecta GT aortic valve will no longer be sold in the US tissue sAVR market, the manufacturer has revealed, because of increased structural valve degeneration. According to the relevant regulatory frameworks, Abbott is currently starting inventory-related activities for leftover Trifecta and Trifecta GT valves worldwide. Some of Abbott's initial shares will probably be transferred to Edwards Lifesciences because Abbott currently possesses just one product on the US tissue sAVR market.

July 2023: The annual sales and profit predictions for Edwards Lifesciences Corp were marginally increased, but slower-than-expected growth in revenue in the manufacturer of artificial heart valves caused its shares to decline 6% after the bell. However, heart surgeries have not returned as quickly as other procedures, affecting medical equipment producers counting on a robust rebound. Staffing shortages at American hospitals have improved, which has increased non-urgent treatments delayed by the epidemic. This is partially because some surgeries take longer to complete—four to six months from the initial diagnosis. During a conference call, the business stated that lower-than-expected growth in the market and competition trialing in the initial half of this year were still putting pressure on sales in Japan.

List of cardiac implants Key companies in the market

Abbott (US)

Amg International (Germany)

Edwards Life Sciences Corporation (US)

Braun Melsungen AG (Germany)

Biotronik(US)

Boston Scientific Corporation (US)

LivaNova PLC (UK)

Medtronic PLC (US)

Syncardia Systems, Inc (Arizona)

Terumo Corporation (Japan)

Cardiac Implants Market Highlights:

Cardiac Implants Market Size

Cardiac Implants Market Trends

Cardiac Implants Market Analysis

Cardiac Implants Market Share

Cardiac Implants Market Highlights:

Cardiac Implants Market Trends

Cardiac Implants Market Analysis

Cardiac Implants Market Share

Cardiac Implants Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.